Genentech have announced that its ongoing Phase III study of Avastin (bevacizumab) in patients with early-stage colon cancer will continue as planned.… more →
Kinase Newsdavidkhorram wrote 1 week ago: In the June 2009 issue of Ophthalmology Soheilian et al, out of Tehran, published an important paper … more →
seewell wrote 1 month ago: The Wall Street Journal “Health Blog” reported that the Centers for Medicare & Medic … more →
davidkhorram wrote 1 month ago: A study in the September 2009 issue of Retina by Huang et al. out of Taiwan is titled “Intravi … more →
Paul Cacciatore wrote 2 months ago: Women with advanced ovarian cancer lived longer and without their tumors growing after receiving a m … more →
Jim Tucker wrote 3 months ago: URO TODAY: Thalidomide and similar drugs are being assessed as powerful ways to inhibit tumour growt … more →
JBBC wrote 4 months ago: Living Beyond Breast Cancer have both transcript and audio recording of Breaking News from the 2009 … more →
cdhh wrote 4 months ago: Researchers at Massachusetts General Hospital recently discovered that a cancer drug called Avastin, … more →
Paul Cacciatore wrote 5 months ago: The 2009 American Society of Clinical Oncology (ASCO) Annual Meeting was held in Orlando, Florida fr … more →
sakerfa wrote 5 months ago: (SciAm) – Until now, cancer treatments prescribed by veterinarians were human-friendly formula … more →
Sitemaster wrote 7 months ago: We learned a few other interesting tidbits during a variety of sessions and conversations today. For … more →
Paul Cacciatore wrote 9 months ago: From February 5th through 8th, 2009, the Society of Gynecologic Oncologists’ (SGO) held its 40 … more →
bmirtsching wrote 10 months ago: Paclitaxel (Taxol) chemotherapy in combination with Bevacizumab (Avastin) has become a standard trea … more →
bmirtsching wrote 11 months ago: CORT has initiated the SWOG S0717 Study for treatment of metastatic renal cancer that has progressed … more →
smnewsletters wrote 12 months ago: A large observational trial has shown substantially increased survival among patients who continued … more →
bmirtsching wrote 1 year ago: The BRiTE (Bevacizumab Regimens: Investigation of Treatment Effects and Safety) Study was published … more →
bmirtsching wrote 1 year ago: Post-operative chemotherapy for Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC) has become standard … more →
bmirtsching wrote 1 year ago: Chemotherapy is the initial standard-of-care treatment for unresectable (stage IIIB/IV) non-small ce … more →
bmirtsching wrote 1 year ago: CORT has conducted research and treatment studies with the monoclonal anti-EGFR (anti-epidermal grow … more →
crimsoncanary wrote 1 year ago: Genentech have announced that its ongoing Phase III study of Avastin (bevacizumab) in patients with … more →